boitr

7/29/2019 boitr

1/8

Market Scenario | AnalyZ Research Team

ANALYZ

RESEARCH

SOLUTIONS

PVT LTD

INDIAN BIOTECHNOLOGY INDUSTRY OUTLOOK

2012

7/29/2019 boitr

2/8

AnalyZ Research Solutions Pvt Ltd Page 2

Main Facts

The Biotechnology industry in India to reach $11.6 billion by 2017-Global Industry Analysis The opportunities for investors in Biotech industry are manifold. In 2010-11 the Indian Biotech industry registered 21.5% growth, touching $4 billion mark

clocking Rs 18,399.34 Cr-Source:Bio Specturm

The BioPharma segment continues to dominate biotech industry with 61.77% share in theoverall revenue.

Disservices occupies 18.82% share, followed by Biafra with 14% share. In Asia Pacific market, India occupies 28.66% market share. India is in 12th rank in the world in biotechnology and 3rd largest in Asia-Pacific after Japan and

Korea. (Source: CII)

The Sector employees approximately 20,000 scientists and over 352 companies drive it towardsfurther growth.

Karnataka is the Biotech Capital of India

Biotech Industry:

Market Size 2010-11

Source: Bio Sprectrum, June 2011

According to the ninth annual survey conducted by the Association of Biotechnology-Led

Enterprises (ABLE) and a monthly journal, Bio Spectrum, the Indian biotech industry surges to

$4 billion with the registered growth of 21.5% with revenues of Rs 18,399.34 Cr.

BioPharma

61%

BioServices20%

BioAgri

14%

BioIndustrial

4%BioInformatics

1%

Market Share 2010-11

BioPharma

BioServices

BioAgri

BioIndustrial

BioInformatics

7/29/2019 boitr

3/8


Biotech Industry Revenues: Segment Wise

Segment 2010-2011 2009-2010 % Change

BioPharma 10,655 8,829 18%

BioServices 3,345.97 2,639 7%

BioAgri 2,480 1,936 5%BioIndustrial 625.94 564 1%

BioInformatics 242.23 231 0%

Total 17,249.34 14,199 31%

Source: Bio Spectrum, June 2011

Companies: Segment Wise-Revenue in Cr FY 2010-11

Segment Company Revenue in Cr

BioPharma Biocon 1483

BioServices Quintiles India 476.25

BioAgri Nuziveedu Seeds 610

BioIndustrial Novozymes 242

BioInformatics Ocimum Biosolutions 65


Biotech Industry: Exports vs. Domestic Sales 2010-11

The very nature of biotech industry is export-driven. The export business went up, total exports in the FY

2010-11 is 8852.34

Cr


0

1,000

2,000

3,000

4,000

5,000

6,000 5,535

2,986.29

74 150.23 106.2

5109.6

259.68

2405

652.94

252.43

Exports

Domestic

7/29/2019 boitr

4/8


Market Forecast

According to the India in Business, Ministry of External Affairs, Govt of India theforecast for 2015 is that the Indian biotech industry would have an annual revenues in

excess of US$13 billion

According to Global Industry Analysis-The Biotechnology industry in India to reach $11.6billion by 2017

Key DriversIndia Advantage

Low Cost Operation in Indiao R&D costs in India is significantly lower, outsourcing to India can save up to 200 milliono Cost of clinical trials is 60% lower compared to global marketso Clinical trials take significantly lesser time in India

Large HR Pool- Skilled Professionalso 5000 PhDs and 1000 Post doctoral in biosciences related fields

Increasing Government Supporto 100% foreign equity investment is possible in manufacturing of all drugs except

recombinant DNA products and cell targeted therapies.

o Single window processing mechanism for all biotech projects involving FDI(Foreign Direct Investment) of US$22 million or more under the Foreign

Investment Implement Authority (FIIA) with its Fast Track Committee (FTC)

existing in Department of Biotechnology.

o Depreciation allowance on plant & machinery rose from 25 to 40%.o Customs duty exemption on goods imported in certain cases for R&D.o Customs & excise duty exemption to recognized Scientific & Industrial Research

Organizations (SIRO)

o 150% weighted tax deduction on R&D expenditureo 3 years excise duty waiver on patented products.o 100% rebate on own R&D expenditure.o 125% rebate if research is contracted in public funded R&D institutions.o Joint R&D projects are provided with special fiscal benefits

Favorable IP Climateo Indian Copyright Act, 1957

7/29/2019 boitr

5/8


o The Patent Act, 1970o Indian Patents and Design Act, 1972o The Trademarks Act, 1999o Biotechnology Patent Facilitating Cell (BPFC)o Foundation of Biotechnology Awareness and Education (FBAE)o National Research Development Corporation (NRDC)

Mayor Players in Biotechnology Industry

Biocon

According to Bio Spectrum-ABLE top 20 survey 2011 Biocon ranks the 1 st position with Rs.1483 Cr. The

company started by Dr.Kiran Mazumdar-Shaw in the year 1978, with focus on Biopharmaceuticals.

Serum Institute of India

Ranks 2nd position with Rs.1041 Cr, the company started in the year 1966, by Dr.C. S. Ponnawala, the

business activity of serum institute is manufacturing and marketing of lifesaving immunologicals, the

H1N1 vaccine boosts the company to the topline.

Panacea Biotech

Ranks 3rd position with Rs.928.41 Cr, started in the year 1978, headed by Dr.Rajesh Jain, the business

activity of Panacea is Pharmaceuticals, Biopharamaceuticals and Vaccines

Nuziveedu Seeds

Ranked 4th position with Rs.610 Cr, started in the year 1990, headed by Dr.M.Prabhakar Rao, the

business activity of Nuziveedu Seeds is production and marketing of agri biotechnology products.

Reliance Life Sciences

Ranked 5th position with Rs.490 Cr, started in the year 2002, headed by Mr.K.V Subramaniam, the

business activity of Reliance Life Sciences is research initiative in medical, plant and industrial

biotechnology.

7/29/2019 boitr

6/8


Quintiles India

Ranked 6th position with Rs.476.25 Cr, started in the year 1979, headed by Dr.Farnaaz N, the business

activity of Quintiles India is offering clinical, commercial and capital solutions. Quintiles established a

leading position in conducting clinical studies.

Novo Nordisk India

Ranked 7th position with Rs.462 Cr, started in the year 1990, headed by Mr.Melvin Oscar DSouza, the

business activity of Nordisk India is Diabetes care, growth hormone and homeostasis maintenance

products . Novo continues to lead the insulin market. It is the largest company in the world in diabetes

care accounts for 55% of insulin market in India.

Rasi Seeds

Ranked 8th position with Rs.371.88 Cr, started in the year 1973, headed by Dr.M Ramasami, the business

activity of Rasi Seeds is production and marketing of agri-biotechnology products.

Karnataka-Indias Biotech Hub

The Biotech capital of India 60% of biotech companies are having base in Bangalore 50% of the total revenues in national biotechnology sector Growth in industrial output of Karnatakas biotech companies CAGR 11% per annum Extensive Intellectual Capital

o 12 Biotechnology finishing schools under millennium biotech policy IIo 103 R&D Centers

Extensive Industrial Infrastructure

o Sector focused SEZs-Mysore, Mangalore, Hubli-Dharwar, Belgaum, Shimoga, Gulbarga,Kolar & Mandya

o 86 acre Bitochnology park-Bangalore Helix with 52 acre Alexandria Knowledge Park inBangalore

Pro Industry policy-State Millennium Biotech Policy II 2010, State Industrial Policy 2009-14o K-Bio Venture capital fund of US$ 10.4 million with 26% stake holding by GoKo Under Biotech policy, financial support of 20% of the project cost for PPP-based projects

for creation biotech parks.

7/29/2019 boitr

7/8


Biotech Clusters in India

Investment Opportunities

The following thrust areas offer tremendous scope for potential investment in theBiotechnology sector

Agriculture and Plant Biotechnology Medicinal and Aromatic plants Animal Biotechnology Aquaculture and Marine Biotechnology Seri biotechnology Stem Cell Biology Human Genetics and Genome Analysis Environmental Biotechnology Microbial and Industrial Biotechnology Healthcare Bio-Fuels Bio Pesticides Bio-Informatics Software Support

7/29/2019 boitr

8/8


AnalyZ Provides

Full Length Market Reports

Investment Opportunities

Competitor Landscaping

Cost Benefit AnalysisTechnology Collaborations with University Researchers

Market Surveys

Prescription Studies

Client Customized Research and Reports

Contact:

AnalyZ Research Solutions Pvt Ltd.,

46/A, I Main Road, III Phase,

J. P. Nagar, Bangalore: 560 078

Phone: 080 41113911

Email:[email protected]

Website: www.analyzresearch.com
mailto:[email protected]:[email protected]:[email protected]:[email protected]

boitr

Documents

Transcript of boitr